HeyJaredBeth Mole
- Indexed articles, last 90 days
- 61
- Latest publication
- Sep 30, 2026
- Outlet visibility, for arstechnica.com
- Top 50K sites
- Earliest in this view
- Jul 7, 2026
Latest articles
RFK Jr. thinks AI will free us from the "tyranny" of medical facts, expertise (opens the original)
Read excerpt
At a Make America Healthy Again event Tuesday, anti-vaccine Health Secretary Robert F. Kennedy opened a “fireside chat” with Vice President JD Vance on the topic of artificial intelligence. While MAHA generally coalesces around things like healthy lifestyles and mistrust of drugmakers, Kennedy quickly turned to extolling the potential of artificial intelligence, surprising Vance, who said he was expecting to discuss “weight loss and acid, not AI.” Kennedy boasted that the Trump administration is
Most powerful obesity drug yet: People lost up to 25% of weight in trial (opens the original)
Read excerpt
Researchers published late-stage clinical trial data today for the latest obesity drug, retatrutide—expected to be the most powerful formula yet—and the results appear in line with high expectations. Patients with obesity on the highest retatrutide dose lost an average of 25 percent of their body weight after 80 weeks, and an average of 30 percent after an extension period to 104 weeks. Overall, more than a third of participants taking retatrutide lost 30 percent or more of their weight. The dru
To keep drug prices high, pharma has been piling up the patents (opens the original)
Read excerpt
The cost of healthcare in general is a debilitating, pre-existing condition for Americans. But the high prices of prescription drugs usually stand out as a pain point. While there are many insidious reasons why Americans pay more—often far more—for their medicines than people in peer countries, exploitation of the US patent system is an obvious one. A study published Monday in JAMA highlights just how much patent exploitation has grown since 1990. In that time, researchers found that the number
Can Trump ever be wrong? His pick to lead FDA refused to say. (opens the original)
Read excerpt
Heidi Overton, President Trump’s nominee to lead the Food and Drug Administration, went before the Senate health committee Thursday, facing questions about her stances on vaccines, flavored vapes, birth control, and abortion, among other issues. She spent nearly two hours stonewalling senators, even on softball questions. Overton, a physician with a doctoral degree in clinical investigation, is currently the deputy assistant to the president for domestic policy. She previously worked at a conser
Trump admin using AI to deny medical care for seniors in disastrous experiment (opens the original)
Read excerpt
In January, the Trump administration rolled out a pilot program that uses artificial intelligence to authorize or deny certain types of care for patients with Medicare—a federal healthcare program for seniors that previously hasn’t required doctors to get any such pre-approval, called prior authorization. Not long after, media outlets began relaying the disastrous outcomes: technical difficulties, long delays in decisions and care, puzzling denials, frustrated doctors, and patients suffering in
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For arstechnica.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.